NEWS
BLOG
 
 

Upcoming Events:

Prize4Life is planning a gala fundraiser and art auction to be held at the Roger Smith Hotel (501 Lexington Avenue, New York, NY). Scheduled for late May, the event will bring together collectors, artists, and socialites who are passionate about treating and curing Lou Gehrig's Disease. The Roger Smith Hotel, a classy, dynamic venue in midtown Manhattan, is home to The Lab gallery for performance and installation, and hosts two regular music series.

Prize4Life is working with famed auctioneer Jamie Niven of Sotheby's Art Auction House for the event. We are seeking donations of artwork that can be auctioned off to benefit Prize4Life. Prize4Life is a registered not-for-profit organization, and donations of artwork are tax-deductible to the full extent allowed by law. Shipping will be covered by the organization.

Sponsorship opportunities for galleries and businesses are available on several levels. Please contact Meghan Kallman, Prize4Life Marketing & Communications Manager, if interested: mkallman@prize4life.org.

Prize4Life In the News:

Conquering Innovation Fatigue: Collaborative Innovation, Altruistic Incentives, and Innovation Competitions: Prize4Life Offers an Exciting Case Study
Newsweek: Help Mouse with Lou Gehrig's Disease.  Win $1 Million.
Jerusalem Post: Prize named for Israeli ALS patient offered for successful research into the neurological disease

Weekly Digest:

If you would like to receive Prize4Life's weekly digest of ALS, industry, and philanthropy news, please email your request to Meghan.

Prize4Life News & Press Releases:

Rasheda Ali and Chaim Lebovits discuss campaign for a cure
Posted on: February 24, 2010
BrainStorm Cell Therapeutics discusses progress towards ALS treatment on Fox News


California Stem Cell and ALS Therapy Development Institute Extend Their Collaboration to Advance Potential Stem Cell Assisted Therapy for ALS
Posted on: February 3, 2010
Collaboration will evaluate stem cell-derived product for the treatment of ALS


Project A.L.S., Packard Center partner to provide $15 million for ALS research
Posted on: February 1, 2010
Organizations partner on P2 ALS initiative


Scientists identify role of key protein in ALS
Posted on: January 13, 2010
TDP-43 causes neuronal degeneration when mislocated


New ALS Drug Slips Through Phase 2 Trials
Posted on: January 6, 2010
A drug already used to treat symptoms of epilepsy has potential to slow the muscle weakening in ALS



News Archive:
Prize4Life and The Jackson Laboratory partner in fight against ALS

Sangamo says early data from ALS study is positive


Prize4Life Teams With Jackson Laboratory

American-Israeli company closes in on ALS treatment

BrainStorm Heralded for Stem Cell Therapy Potential

Mark Wetzel, Rebecca Dalton Join Prize4Life's Board of Directors

Sepsis treatment 'may slow Lou Gehrig's disease'

Prize4Life Marks One-Year Anniversary of Avi Kremer ALS Treatment Prize

Brainstorm Announces Milestone Towards ALS Clinical Trials

A Randomized ALS Clinical Trial of Lithium Carbonate with Riluzole vs. Placebo Shows No Benefit

Neuralstem, Inc., receives FDA approval for Phase 1 ALS clinical trial

Prize4Life and the Alzheimer Research Forum announce ALS Forum!

2008 Financial Reports Now Available Online

Dr. Vicki Sato and Dr. David Meeker join Prize4Life's Board!

We made the big time!

Prize4Life and the Alzheimer Research Forum Announce Launch of New Web-Portal for ALS Research

$1M Biomarker Prize Challenge re-posted on InnoCentive

Prize4Life awards $100,000 in prizes

Prize4Life on Facebook and Twitter

Prize4Life Celebrates 3rd Birthday!

Prize4Life Exhibiting in Seattle

Event in Culver City, California

Oct 21, 2008: Prize4Life Launches $1M ALS Treatment Prize

Sept 23, 2008: James E. Giessler Joins Prize4Life